HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammatory cytokines in maternal serum between women with threatened miscarriage and normal pregnancy.

AbstractOBJECTIVE:
To compare the levels of proinflammatory cytokines in women with threatened miscarriage and normal pregnancy.
METHODS:
This study was a longitudinal study. Consenting women with normal pregnancy and those admitted on account of threatened miscarriage at an estimated gestational age of 6-10 weeks were included in the study. The proinflammatory cytokines interleukin-2 (IL-2) and interferon-γ (IFN-γ) and the anti-inflammatory cytokines IL-4 and IL-13 were measured at the diagnosis of threatened miscarriage (baseline) and in the 13th week of pregnancy. The χ2 test of association was used to examine the relationship between the pregnancy type and demographic characteristics; clinical history and gynecologic history. Student t test was used to compare the selected cytokine between women with threatened miscarriage and normal pregnancy.
RESULTS:
There was a significantly higher IL-2 (P = 0.033), IFN-γ (P < 0.001), and IL-13 (P < 0.001) in women with threatened miscarriage than in women with normal pregnancy at the baseline. At the follow up, the results revealed a significantly higher IFN-γ level (P < 0.001) and IL-4 (P = 0.019) in women with threatened miscarriage than in women with normal pregnancies.
CONCLUSION:
Proinflammatory cytokine profiles were associated with a higher risk of threatened miscarriage.
AuthorsLawal Adewale Hakeem, Yusuf Olatunji Bello, Gbolahan O Obajimi, Abdul Fatai Adekunle Onifade, Bolaji Ahmed, Ayodele O Arowojolu, Imran Oludare Morhason-Bello
JournalInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Int J Gynaecol Obstet) (Jul 18 2023) ISSN: 1879-3479 [Electronic] United States
PMID37464913 (Publication Type: Journal Article)
Copyright© 2023 International Federation of Gynecology and Obstetrics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: